Soleno Therapeutics 13G Filing Shows Janus Henderson Group plc Holds 10.1% Stake In Co
Portfolio Pulse from Benzinga Newsdesk
Janus Henderson Group plc has acquired a 10.1% stake in Soleno Therapeutics, according to a 13G filing with the SEC.
October 06, 2023 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Janus Henderson Group's acquisition of a 10.1% stake in Soleno Therapeutics could potentially influence the company's stock price.
The acquisition of a significant stake by a major investment group like Janus Henderson can often lead to increased investor confidence and potentially a rise in the stock price. However, the actual impact will depend on the market's overall perception of this move.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100